This review discusses cardiovascular risk in type 1 diabetes mellitus and the role of non-invasive techniques for screening subclinical vascular damage.
May inform subclinical vascular screening in type 1 diabetes; leaves open prospective outcome validation.
Commonly cardiovascular risk (CVR) is linked to type 2 diabetes mellitus as this type is known to be part of the metabolic syndrome, which includes other cardiovascular factors such as hypertension, dyslipidemia. Inversely, CVR of type 1 diabetes mellitus (T1DM) is currently being debated apart from the occurrence of diabetic nephropathy (DN). For this, we did a review of CVR in patients with T1DM complicated or not with DN. The place of novel non-invasive techniques in screening of subclinical vascular damage is also discussed in this review.
No takes yet. Share an insight, caveat, or question.
Ines BenHadj Slama Slim (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: